Stop the discrimination for people cured of cancer, however forced to declare their history of cancer patients when it comes to applying for a mortgage, taking out insurance, adopting a minor. To address the issue the senator of Italy alive Donatella Conzatti, author of a bill for the right to be forgotten oncology. The purpose of the provision is to “guarantee people suffering from oncological pathologies the right not to declare information about their previous illness, after a certain period of time has elapsed from the date of conclusion of the therapeutic treatments, and in the absence of relapses or relapses”. , recalls the exponent of Iv, “among the most significant obstacles that former cancer patients, clinically cured people, must face, there is certainly strong bureaucratic discrimination and inequity in accessing financial and banking services such as obtaining of mortgages, in the stipulation of insurance policies, such as life insurance, and in requests for the adoption of minors, as for the use of these services it is necessary to declare whether one has had an oncological pathology “. Moreover, “in February 2021 the European Commission presented the European Plan for the fight against cancer”, with which, among other things, “it requires the commitment, on the part of the Member States, to provide for rules in support of the right to ‘oblivion’ that change practices in the financial services sector “. An invitation already accepted in France, Belgium, Holland, Luxembourg and Portugal. Hence the Conzatti bill, which “recognizes the right of people who have been affected by oncological pathologies, and who are clinically cured, not to suffer discrimination in accessing banking and financial services and in adopting minors”. For this reason “when stipulating insurance contracts and contracts concerning access to banking and financial services, the consumer cannot be asked for information on his state of health relating to previous oncological pathologies, when two years have elapsed from the cure, or two years from the end of active treatment in the absence of relapses or relapses of the disease “. Similarly, it is expected that the requirements and investigations for adoption cannot have as their object an oncological pathology, if also in this case two years have elapsed from the cure.
Welcome! Log into your account
Recover your password
A password will be e-mailed to you.